Type 2 Asthma Learning Hub
Welcome to Type 2 Asthma learning hub gathering key medical educational ADVENT resources on the role of type 2 in asthma.
Type 2 asthma is a common phenotype of asthma, characterized by key cytokines IL-4, IL-13, and IL-5, as well as elevated type 2 inflammatory biomarkers as FeNO, and eosinophils, or the need for maintenance OCS. Type 2 inflammation is evident in up to 88% of patients with severe asthma, representing a substantial portion of the disease burden associated with asthma. Explore the resources below better understand the role of type 2 inflammation in asthma.
Type 2 asthma is a common phenotype of asthma, characterized by key cytokines IL-4, IL-13, and IL-5, as well as elevated type 2 inflammatory biomarkers as FeNO, and eosinophils, or the need for maintenance OCS. Type 2 inflammation is evident in up to 88% of patients with severe asthma, representing a substantial portion of the disease burden associated with asthma. Explore the resources below better understand the role of type 2 inflammation in asthma.
Disease Burden and Pathophysiology of Type 2 Asthma
Understand the burden in patients with uncontrolled asthma and the underlying pathophysiological mechanisms leading to the clinical symptoms of asthma.
Biomarkers for Type 2 Asthma
Explore in greater detail which are the key mediators in Type 2 asthma.
Asthma Events of Interest
Asthma Events of Interest highlight congresses and latest educational opportunities relating to understanding the science of Asthma.
ATS 2024 | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?
Join experts Mario Castro, Nicola Hanania, and Stephanie Christenson for an educational symposium on the real-world impact of underlying type 2 inflammation on the patient burden of asthma and COPD.
Related events
Test your knowledge
